HeartSciences | Company

About HeartSciences

HeartSciences combines current research and understanding of heart disease along with the latest advances in wavelet signal processing and artificial Intelligence to develop breakthrough technology for the early detection of heart disease.

Formed in 2008, HeartSciences (formerly known as Heart Test Laboratories) is a privately held medical technology company located in the Dallas-Fort Worth metroplex, the largest economic area in the Southern United States. For a decade, HeartSciences has been dedicated to the development of accurate, affordable cardiac testing tools for the early detection of heart disease.

To date, HeartSciences has invested more than $30M in research and development in an effort to fundamentally improve the sensitivity of an electrocardiograph (ECG/EKG) for the early detection of heart disease.

MyoVista^® Wavelet ECG (wavECG™) Technology applies proprietary use of Continuous Wavelet Transform (CWT) signal processing and represents HeartSciences first product release from years of research and development.

Mission

Enabling accurate, affordable screening for the early detection of heart disease.

The Problem

Heart Disease Is the Leading Cause of Death Worldwide

Closing the Diagnostic Gap requires more effective low-cost frontline tools for Heart Disease Screening and Testing

Partial List of Cardiac Testing Methods

Conventional ECGs are typically used for symptomatic patients for diagnostic evaluation of chest pain
ECG based stress test – Higher cost but provides improved sensitivity to ischemia over resting ECG
CT Scan – Maybe used with or without contract media, too expensive for frontline screening
Echocardiogram – Uses Doppler acoustical to evaluate structural and mechanical properties of the heart
Nuclear Stress Test – Commonly used noninvasive method for detecting coronary arterial disease
Angiogram – Invasive diagnostic evaluation of coronary artery disease (Gold Standard)

Conventional ECG – Lack of Innovation

The MyoVista wavECG Device provides low cost advanced testing to assist in the assessment of heart disease.

The MyoVista wavECG Device provides advanced testing to help detect cardiac disease, the leading cause of death and largest disease management spend in healthcare.

Effective testing can help shift focus to earlier lower cost treatments and better patient outcomes.

Targeting the Diagnostic gap – The MyoVista wavECG Device helps to address a lack of high quality tools for low cost heart testing

The MyoVista wavECG Device is a simple, non-invasive, electrophysiology based medical device with innovative and intuitive user interface.

Our Mission: Enabling accurate, affordable screening for the early detection of heart disease

The MyoVista wavECG Device uses additional analysis of the ECG signal using Wavelet Signal Processing

Wavelet Signal Processing is a well-known method allowing for spectral analysis of a signal

MyoVista wavECG Technology uses innovative patented methods of signal analysis

MyoVista wavECG Technology analyzes the ECG signal using conventional and new data parameters generated from signal processing

Ongoing research and development at HeartSciences is focused on delivering on our mission statement

Incorporates Conventional ECG

Produces conventional ECG tracing with Glasgow Interpretive Analysis and proprietary MyoVista wavECG Informatics reporting

Familiar 12-lead ECG lead placement – no change in clinical workflow

Provides new information related to the acquired ECG signal using wavelet signal processing

Provides additional information using wavelet signal processing related to patient risk of Heart Disease

Leadership

News and Events

Investors Portal Login

HeartSciences enables accurate, affordable screening for the early detection of heart disease. MyoVista^® Wavelet ECG (wavECG™) Technology advances cardiac screening bridging the “diagnostic gap”, detecting cardiac dysfunction. MyoVista is a low cost, easy to adopt test for asymptomatic and symptomatic patients. MyoVista- The Power of Wavelet Signal Processing.

Careers

To submit a resume and coverletter please send documents to careers@heartsciences.com

About HeartSciences

Mission

The Problem

Closing the Diagnostic Gap requires more effective low-cost frontline tools for Heart Disease Screening and Testing

Conventional ECG – Lack of Innovation

Our Mission: Enabling accurate, affordable screening for the early detection of heart disease

Incorporates Conventional ECG

Leadership

Chairman

CEO

Board Members

Management

Clinical Advisors

Non-Clinical Advisors

News and Events

Investors Portal Login

Careers